secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2026-02-24T23:59:59+00:00
Accession:  0001356576-26-000007
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus raises CEO salary to $1.067M, awards $847K bonus and equity grants
---------------------------------------------------------------------------

- CEO salary increased to $1,067,100 from $1,036,000; 2025 bonus $846,930.
- CEO granted options for 341,610 shares and 204,966 PSUs at $50.20 strike.
- CFO salary raised to $525,100 from $504,900; 2025 bonus $233,894.
- CFO gets 17,500 options, 3,000 RSUs, and 3,500 PSUs.
- Three other execs (Bhatt, Rubin, Mottola) also received salary increases and equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000007/0001356576-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000007/supn-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001356576-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer